Mehtap Aydın

2.1k total citations
54 papers, 544 citations indexed

About

Mehtap Aydın is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Mehtap Aydın has authored 54 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 19 papers in Epidemiology and 9 papers in Applied Microbiology and Biotechnology. Recurrent topics in Mehtap Aydın's work include COVID-19 Clinical Research Studies (12 papers), Antibiotic Use and Resistance (9 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Mehtap Aydın is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Antibiotic Use and Resistance (9 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Mehtap Aydın collaborates with scholars based in Türkiye, United Kingdom and Kuwait. Mehtap Aydın's co-authors include Funda Demirağ, Ebru Çakır, Ebru Ünsal, Sevtap Aydın, Merve Bacanlı, Ahmet Akıcı, Hüseyin Tombuloğlu, Nurşen Başaran, Arif Ahmet Başaran and Tevfik Tolga Şahin and has published in prestigious journals such as PLoS ONE, Advanced Science and International Journal of Antimicrobial Agents.

In The Last Decade

Mehtap Aydın

50 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehtap Aydın Türkiye 14 156 152 82 72 58 54 544
Lê Thị Phương Thảo Australia 17 152 1.0× 130 0.9× 32 0.4× 124 1.7× 22 0.4× 47 798
Simona Iftimie Spain 13 99 0.6× 153 1.0× 23 0.3× 82 1.1× 20 0.3× 38 435
Marty Chaplin United Kingdom 14 103 0.7× 229 1.5× 58 0.7× 86 1.2× 14 0.2× 32 703
Lei Tian China 17 175 1.1× 202 1.3× 128 1.6× 199 2.8× 98 1.7× 51 1.1k
Fengxue Zhu China 13 129 0.8× 182 1.2× 47 0.6× 226 3.1× 23 0.4× 48 744
Yuki Hayashi Japan 13 265 1.7× 76 0.5× 83 1.0× 200 2.8× 125 2.2× 30 800
Saroj Khatiwada Nepal 16 133 0.9× 101 0.7× 24 0.3× 209 2.9× 25 0.4× 44 820
Hyungmin Lee South Korea 13 70 0.4× 71 0.5× 75 0.9× 89 1.2× 20 0.3× 44 509
Giacomo Casalini Italy 12 164 1.1× 334 2.2× 30 0.4× 60 0.8× 71 1.2× 27 520

Countries citing papers authored by Mehtap Aydın

Since Specialization
Citations

This map shows the geographic impact of Mehtap Aydın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehtap Aydın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehtap Aydın more than expected).

Fields of papers citing papers by Mehtap Aydın

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehtap Aydın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehtap Aydın. The network helps show where Mehtap Aydın may publish in the future.

Co-authorship network of co-authors of Mehtap Aydın

This figure shows the co-authorship network connecting the top 25 collaborators of Mehtap Aydın. A scholar is included among the top collaborators of Mehtap Aydın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehtap Aydın. Mehtap Aydın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koç, Meliha Meriç, Ayşe Batırel, Emel Yılmaz, et al.. (2025). Emerging West Nile virus infections in Türkiye. European Journal of Clinical Microbiology & Infectious Diseases. 44(7). 1659–1666. 1 indexed citations
2.
Aydın, Mehtap, et al.. (2024). Use of high-dose steroid therapy: addition of anakinra in the treatment of severe COVID-19. Revista da Associação Médica Brasileira. 70(1). e20230671–e20230671. 1 indexed citations
3.
Aydın, Mehtap, et al.. (2023). Clinical characteristics and risk factors associated with secondary bacterial pneumonia among COVID-19 patients in ICU. The Journal of Infection in Developing Countries. 17(10). 1387–1393. 1 indexed citations
4.
Çağlayık, Dilek Yağcı, Elif Tükenmez Tigen, Uluhan Sili, et al.. (2023). Prevalence of Polypharmacy and Potential Drug–Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS Patient Care and STDs. 37(3). 138–145. 4 indexed citations
5.
Yavuz, Serap Şimşek, Hasan Selçuk Özger, Aysun Benli, et al.. (2023). The Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023. Klimik Dergisi/Klimik Journal. 36(2). 86–123. 6 indexed citations
6.
Başaran, Mustafa, et al.. (2023). Effects of COVID-19 Disease on DNA Damage, Oxidative Stress and Immune Responses. Toxics. 11(4). 386–386. 11 indexed citations
7.
Yavuz, Serap Şimşek, Özlem Altuntaş Aydın, Mehtap Aydın, et al.. (2022). Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients Who Were Either Fully Vaccinated with Coronavac or Not: An Analytical, Cross Sectional Study. Vaccines. 10(5). 733–733. 2 indexed citations
8.
Aydın, Mehtap, et al.. (2022). Clinical characteristics and risk factors associated with severe disease and outcome of patients with COVID-19. The Journal of Infection in Developing Countries. 16(3). 435–444. 4 indexed citations
9.
Aydın, Mehtap, et al.. (2022). Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial. PubMed. 4(2). 116–121. 1 indexed citations
10.
Alkurt, Gizem, Ahmet Murt, Zeki Aydın, et al.. (2021). Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey. PLoS ONE. 16(3). e0247865–e0247865. 17 indexed citations
11.
Açıksarı, Gönül, Yasemin Çağ, Adem Atıcı, et al.. (2021). Evaluation of Modified ATRIA Risk Score in Predicting Mortality in Hospitalized Patients With COVID-19. The American Journal of the Medical Sciences. 362(6). 553–561. 3 indexed citations
12.
13.
Aşan, Ali, Sevgi Özkan, Mehtap Aydın, et al.. (2017). Factors affecting responsiveness to hepatitis B immunization in dialysis patients. International Urology and Nephrology. 49(10). 1845–1850. 30 indexed citations
14.
Aydın, Sevtap, Tevfik Tolga Şahin, Merve Bacanlı, et al.. (2016). Resveratrol Protects Sepsis-Induced Oxidative DNA Damage in Liver and Kidney of Rats. Balkan Medical Journal. 33(6). 594–601. 42 indexed citations
15.
Aydın, Mehtap, et al.. (2016). The Rational Use of Antibiotics in Dentistry: Review. Turkiye Klinikleri Journal of Dental Sciences. 23(1). 33–47. 3 indexed citations
16.
Aydın, Mehtap, et al.. (2014). Detection of Helicobacter pylori in adenoid tissue by real-time polymerase chain reaction. The Turkish Journal of Ear Nose and Throat. 24(2). 78–82. 3 indexed citations
17.
18.
Aydın, Mehtap, et al.. (2009). The cytological evaluation of bladder and lung carcinoma rates on the workers exposed to industrial chemicals.. DergiPark (Istanbul University). 66(2). 49–57. 2 indexed citations
19.
Çakır, Ebru, Funda Demirağ, Mehtap Aydın, & Ebru Ünsal. (2008). Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis. Diagnostic Cytopathology. 37(1). 4–10. 41 indexed citations
20.
Çelik, İ̇lhami, et al.. (2007). Tavşanlarda intraabdominal adezyonların önlenmesinde fluniksin meglumine ve mepiramin maleatin etkileri üzerine deneysel araştırma. 23(1). 41–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lê Thị Phương Thảo Breakdown of academic impact, for papers by Simona Iftimie Breakdown of academic impact, for papers by Marty Chaplin Breakdown of academic impact, for papers by Lei Tian Breakdown of academic impact, for papers by Fengxue Zhu Breakdown of academic impact, for papers by Yuki Hayashi Breakdown of academic impact, for papers by Saroj Khatiwada Breakdown of academic impact, for papers by Hyungmin Lee Breakdown of academic impact, for papers by Giacomo Casalini
Rankless by CCL
2026